OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO. Stock

Certificat

DE000GZ0G9F2

Real-time BOERSE MUENCHEN 04:26:55 2024-05-22 am EDT
20.07 EUR +0.15% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO.
Current month-1.76%
1 month-1.96%
Date Price Change
24-05-22 20.07 +0.15%
24-05-21 20.04 +0.75%
24-05-20 19.89 -0.15%
24-05-17 19.92 +0.50%
24-05-16 19.82 +0.20%

Real-time BOERSE MUENCHEN

Last update May 22, 2024 at 04:26 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GZ0G9F
ISINDE000GZ0G9F2
Date issued 2022-09-21
Strike 452.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 20.38
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 24.09
Lowest since issue 14.76
Spread 0.1
Spread %0.50%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
234.9 USD
Average target price
279 USD
Spread / Average Target
+18.79%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW